Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service (NHS) clinical trial that is being used to fast-track the biological to licensure. The vaccine, iSCIB1+—also known as ImmunoBody—is a DNA-based treatment designed to boost the immune system’s ability to target and remember melanoma cells.1 […]
Bayer Petitions U.S. Supreme Court to Stop Roundup Herbicide Lawsuits
Bayer, Inc. has filed a petition with the U.S. Supreme Court seeking review of a lower court decision finding that its popular weed killer Roundup causes cancer. The Missouri Supreme Court declined to hear Bayer’s appeal of the lower court’s decision, so the drug giant went to the highest court in the land.1 This is […]
Early Onset Breast Cancer is on the Rise in Younger Women
Data from recent years shows that early onset breast cancer is on the rise, particularly in younger women under age 50. The breast cancer incidence rate is increasing at 1.4 percent annually in those under the age of 50, compared to 0.7 percent for women over the age of 50.1 While breast cancer incidence in […]
Popular Cold Medicine Contains Cancer-Causing Benzene
According to a recent analysis by Bloomberg, generic store-brand versions of Mucinex, a popular cold medicine containing guaifenesin that is used by millions of Americans during cold and flu season, have been found to contain benzene. A cancer-causing chemical linked to leukemia and other serious blood disorders, benzene is the same carcinogenic compound found in […]
Top Killers in America
A study published in 2016 in the British Medical Journal (BMJ) identified “medical error” as the third leading cause of death in the United States. Study authors reported that medical errors are responsible for the deaths of about 251,000 Americans each year—up from the nearly 100,000 Americans estimated by the Institute of Medicine (IOM) in […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]